One-year evaluation of automated insulin delivery systems in adults with type 1 diabetes
This study confirms that, after 12 months of routine clinical use, the use of commercially available automated insulin delivery (AID) systems significantly improves glycemic control in individuals with type 1 diabetes. However, the degree of improvement varies depending on the specific system used.These findings underscore the importance of selecting and optimizing AID systems individually to maximize clinical benefits in type 1 diabetes management.
Authors
- Lucía Díaz-Naya
- Edelmiro Menéndez Torre (ORCID: https://orcid.org/0000-0002-9548-7821)
- Miguel García‐Villarino (ORCID: https://orcid.org/0000-0002-0186-2804)
- Diego Rivas‐Otero (ORCID: https://orcid.org/0000-0001-6119-8848)
- Jessica Ares (ORCID: https://orcid.org/0000-0002-4307-8145)
- Carmen Lambert (ORCID: https://orcid.org/0000-0002-7929-4990)
- Elías Delgado (ORCID: https://orcid.org/0000-0001-6114-9712)
- Pedro Pujante (ORCID: https://orcid.org/0000-0002-4146-0690)
- Brenda Veiguela
- Gala Gutiérrez Buey
- Elsa Villa-Fernández (ORCID: https://orcid.org/0000-0001-5702-8985)
- Tomás González‐Vidal (ORCID: https://orcid.org/0009-0006-9147-1757)
- Ana Victoria García (ORCID: https://orcid.org/0000-0002-2266-2940)
Institutions
- Universidad de Oviedo (ES)
- Instituto de Salud Carlos III (ES)
- Centre for Biomedical Network Research on Rare Diseases (ES)
- Hospital Universitario Central de Asturias (ES)
- Hospital Universitario De Cabueñes (ES)
- Instituto de Investigación Sanitaria del Principado de Asturias (ES)
Publication Details
- Journal
- Frontiers in Digital Health
- Published
- 2025-07-01
- DOI
- https://doi.org/10.3389/fdgth.2025.1596188
- Citations
- 7
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 9.06
Funders
- Gobierno del Principado de Asturias
- European Commission
- Instituto de Salud Carlos III